Mohamed F Elshal

5PUBLICATIONS
9CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 18, 2026
Atorvastatin Enhances Doxorubicin Efficacy in Breast Cancer Through Convergent Disruption of Drug Efflux, Heat-Shock Response, and DNA Hypermethylation.

|Sep 30, 2025
Cucurbitacin-E-Glucoside Augments Tamoxifen's Anticancer Efficacy by Targeting PPARγ and NF-kB: In Vivo and In Silico Studies.

Yasmin Sabry, Mohammed A Hussein, Mohamed F Elshal

|Aug 01, 2024
Sitagliptin synergizes 5-fluorouracil efficacy in colon cancer cells through MDR1-mediated flux impairment and down regulation of NFκB2 and p-AKT survival proteins.

Asmaa Eisa, Shaden M Hanafy, Hany Khalil

|Feb 15, 2022
Potential Anticancer Activity of the Furanocoumarin Derivative Xanthotoxin Isolated from Ammi majus L. Fruits: In Vitro and In Silico Studies.

Marwa Y Issa, Mohamed F Elshal, Noha Fathallah

|Nov 01, 2021
Loperamide potentiates doxorubicin sensitivity in triple-negative breast cancer cells by targeting MDR1 and JNK and suppressing mTOR and Bcl-2: In vitro and molecular docking study.

Shenouda G Elia, Ahmed A Al-Karmalawy, Mohamed Y Nasr

Pageof 1

Frequent Collaborators

1 joint publications

Shenouda G Elia

1 joint publications

Ahmed A Al-Karmalawy

1 joint publications

Mohamed Y Nasr

1 joint publications

Marwa Y Issa